✦ LIBER ✦

Pazopanib for the First-Line Treatment of Patients with Advanced and/or Metastatic Renal Cell Carcinoma

✍ Scribed by Kilonzo, Mary; Hislop, Jenni; Elders, Andrew; Fraser, Cynthia; Bissett, Donald; McClinton, Samuel; Mowatt, Graham; Vale, Luke

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NICE guidance on pazopanib for first-lin

✍ Christian Griffiths; Nicola Hay; Frances Sutcliffe; Andrew Stevens 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 213 KB

Pazopanib for the Treatment of Metastati

✍ Amy M. Pick; Kelly K. Nystrom 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 357 KB

Budget impact analysis of first-line tre

✍ Villa, Guillermo; Hernández-Pastor, Luis-Javier 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 244 KB

Cost-Effectiveness of Pazopanib as First

✍ Pepe, C.; Sedlmayer, C.; Machado, M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Evaluation of patients with metastatic r

✍ Joan Carles,Isabel Chirivella,Miguel Ángel Climent… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 155 KB

Treatment outcomes of sorafenib for firs

✍ Takeshi Ueda; Yusuke Imamura; Atsushi Komaru; Satoshi Fukasawa; Tomokazu Sazuka; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB